Vigonvita Life Sciences Co., Ltd. (HKG:2630)
Hong Kong flag Hong Kong · Delayed Price · Currency is HKD
70.05
-5.40 (-7.16%)
At close: Jun 1, 2026

Vigonvita Life Sciences Revenue

In the year 2025, Vigonvita Life Sciences had annual revenue of 102.10M CNY with 762.88% growth.

Revenue
102.10M CNY
Revenue Growth
+762.88%
P/S Ratio
103.33
Revenue / Employee
324.11K CNY
Employees
315
Market Cap
11.74B HKD

Revenue Chart

* This company reports financials in CNY.

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 2025102.10M90.26M762.88%
Dec 31, 202411.83M-187.82M-94.07%
Dec 31, 2023199.65M--

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition